148.78
+0.80 (+0.54%)
Closing price for Sep 25, 2026 from Polygon.io
-
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval
Yahoo Finance · Sep 25, 2026
-
Merck Stock Nearly Doubled Without A Change In Its Revenue Growth
Trefis · Sep 18, 2026
-
Merck Stock Price Forecast. Should You Buy MRK?
StockInvest.us · Sep 25, 2026
-
Bank of America has strong message for Merck stock investors
thestreet.com · Sep 24, 2026
-
Merck & Co., Inc. (MRK) Short Interest & Short Float | Updated Sep 2026 $MRK
MarketBeat · Sep 24, 2026
-
Merck reveals study success, and possible safety worries, for eye drug hopeful
BioPharma Dive · Sep 24, 2026
-
3 Reasons to Sell MRK and 1 Stock to Buy Instead
StockStory · Sep 22, 2026
-
Breakfast News: Why Merck Should Buy Moderna
The Motley Fool · Sep 16, 2026
-
Merck Stock: Is The $70 Billion Pipeline Worth the Premium?
Yahoo Finance · Sep 15, 2026
-
Could You Have Seen Merck Stock’s Pipeline Run Coming?
Trefis · Sep 22, 2026
-
Merck (MRK) Declines More Than Market: Some Information for Investors
Yahoo Finance · Sep 23, 2026
-
Merck (MRK) Outperforms Broader Market: What You Need to Know
Yahoo Finance · Sep 17, 2026
-
Merck & Co. (MRK) is Building a Stronger Future Beyond Its Keytruda Franchise
Yahoo Finance · Sep 17, 2026
-
AZN vs. MRK: Comparing Keytruda, Pipelines and Growth Strategies
Yahoo Finance · Sep 21, 2026
-
Merck Jumps as Winrevair Moves Earlier in PAH
Yahoo Finance · Sep 24, 2026
-
Wall Street Analysts Think Merck (MRK) Is a Good Investment: Is It?
Yahoo Finance · Sep 22, 2026
-
Merck (MRK), What Is Behind The Fresh Attention Now?
Yahoo Finance · Sep 24, 2026
-
Merck Is Up 40% This Year, but Is the Keytruda Rebuild Already Priced In?
Yahoo Finance · Sep 26, 2026
-
Merck Gets CHMP Backing for Keytruda-Padcev Combo in Bladder Cancer
Yahoo Finance · Sep 21, 2026
Headlines via Google News. Links open the original publisher.